Effect of Melatonin on Oxidative Stress Parameters in Levodopa-Treated Parkinson's Disease Patients
NCT07375693
·
clinicaltrials.gov ↗
PHASE2
Phase
ENROLLING_BY_INVITATION
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
MELATONIN (MELATL07959)
Sponsor
Bangladesh Medical University